BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7481376)

  • 1. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
    Wolk SI; Douglas CJ
    J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S; Navarro E; Mateo D
    Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
    Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ
    Parkinsonism Relat Disord; 2004 Oct; 10(7):439-41. PubMed ID: 15465403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of clozapine in Parkinson disease and related disorders.
    Thomas AA; Friedman JH
    Clin Neuropharmacol; 2010; 33(1):14-6. PubMed ID: 20023573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine for psychosis in Parkinson's disease.
    Pfeiffer RF; Kang J; Graber B; Hofman R; Wilson J
    Mov Disord; 1990; 5(3):239-42. PubMed ID: 2388641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
    Retz W; Rösler M; Sitzmann L; Becker T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term clinical experience with clozapine].
    Gelly F; Chambon O; Marie-Cardine M
    Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D; Balas M; Peretz C; Shabtai H; Giladi N
    Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal akathisia in Parkinson's disease: treatment with clozapine.
    Linazasoro G; Martí Massó JF; Suárez JA
    Mov Disord; 1993 Apr; 8(2):171-4. PubMed ID: 8474484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
    Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
    Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS; Friedman JH; Ott BR
    J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.